Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) Shares Outstanding (Diluted Average) (2020 - 2025)

Historic Shares Outstanding (Diluted Average) for Palisade Bio (PALI) over the last 7 years, with Q3 2025 value amounting to $7.5 million.

  • Palisade Bio's Shares Outstanding (Diluted Average) rose 39812.4% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 million, marking a year-over-year increase of 39812.4%. This contributed to the annual value of $1.4 million for FY2024, which is 21062.01% up from last year.
  • Per Palisade Bio's latest filing, its Shares Outstanding (Diluted Average) stood at $7.5 million for Q3 2025, which was up 39812.4% from $4.8 million recorded in Q2 2025.
  • Palisade Bio's Shares Outstanding (Diluted Average)'s 5-year high stood at $12.1 million during Q3 2021, with a 5-year trough of $287702.0 in Q1 2023.
  • In the last 5 years, Palisade Bio's Shares Outstanding (Diluted Average) had a median value of $927254.0 in 2022 and averaged $2.4 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first plummeted by 9195.33% in 2022, then soared by 52432.17% in 2025.
  • Over the past 5 years, Palisade Bio's Shares Outstanding (Diluted Average) (Quarter) stood at $12.1 million in 2021, then crashed by 92.73% to $880311.0 in 2022, then crashed by 48.2% to $456014.0 in 2023, then soared by 210.62% to $1.4 million in 2024, then surged by 427.64% to $7.5 million in 2025.
  • Its last three reported values are $7.5 million in Q3 2025, $4.8 million for Q2 2025, and $4.8 million during Q1 2025.